drugset / Trial / NCT03872830
A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multicenter, randomized, double-blind, placebo-controlled, dose-exploratory phase II clinical trial to evaluating the efficacy and safety of Felbinac Trometamol Injection in the treatment of moderate to severe pain after surgery.Main purpose is preliminary evaluation the effectiveness of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery.Secondary purpose is to explore the dosage regimen of Felbinac Trometamol Injection in the treatment of moderate and severe pain after surgery, and provide data support for later clinical trial.
Timeline
- Start
- 2019-03-27
- Primary completion
- 2019-09-30
- Completion
- 2019-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Felbinac Trometamol | Unknown | 47.13 mg | Intravenous |
| Subject | Felbinac Trometamol | Unknown | 94.25 mg | Intravenous |
| Subject | Felbinac Trometamol | Unknown | 188.5 mg | Intravenous |
Indications
No indication recorded.